ArticleMedicine2026
Global, regional, and national disease burden of paralytic ileus and intestinal obstruction among individuals younger than 20 years, 1990 to 2021: Findings from the Global Burden of Disease Study 2021.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Using Global Burden of Disease Study 2021 data, this study assessed the global, regional, and national burden of paralytic ileus and intestinal obstruction among individuals younger than 20 years from 1990 to 2021 and explored its temporal patterns, inequalities, drivers, and future trends. We extracted global, regional, and national estimates of incidence, mortality, prevalence, and disability-adjusted life years (DALYs), together with age-standardized rates (ASR). Analytical methods included Joinpoint regression, age-period-cohort analysis, inequality and frontier analysis, decomposition analysis, and Bayesian age-period-cohort modeling to project burden to 2050. From 1990 to 2021, global ASR for incidence, mortality, prevalence, and DALYs declined, whereas absolute case numbers increased due to population growth. The burden was highest among children under 5 years and in lower socio-demographic index (SDI) regions. While inequalities in incidence and prevalence were relatively small, mortality and DALYs were disproportionately concentrated in lower-SDI regions, indicating pro-poor inequality. Frontier analysis revealed efficiency gaps in incidence and prevalence management in high-SDI areas, whereas several low-SDI countries approached their potential minimum for mortality and DALYs. Decomposition analysis attributed declining mortality and DALYs to epidemiological improvement and rising case numbers to population growth. All ASRs are projected to decline or stabilize by 2050. While fatal outcomes have improved, rising case numbers and persistent inequalities define the burden. Mortality reduction is driven by care improvements, while demographic growth fuels case increases. Public health strategies must be targeted: high-SDI regions should enhance prevention, low-SDI regions must strengthen acute care, and all efforts should prioritize children under 5.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.